awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43060768-CE32A483-F3D0-42EE-8314-A464F7200275
Q43060768-CE32A483-F3D0-42EE-8314-A464F7200275
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43060768-CE32A483-F3D0-42EE-8314-A464F7200275
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.
P433
Q43060768-CE32A483-F3D0-42EE-8314-A464F7200275
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43060768-CE32A483-F3D0-42EE-8314-A464F7200275
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
92d0638e494c23c66b8e91e38f36aa624d5d3aa6
P433
2
http://www.w3.org/2001/XMLSchema#string